0001209191-17-045116.txt : 20170713
0001209191-17-045116.hdr.sgml : 20170713
20170713193942
ACCESSION NUMBER: 0001209191-17-045116
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170711
FILED AS OF DATE: 20170713
DATE AS OF CHANGE: 20170713
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: G1 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001560241
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263648180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 79 T.W. ALEXANDER DRIVE
STREET 2: 4501 RESEARCH COMMONS, SUITE 100
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-213-9835
MAIL ADDRESS:
STREET 1: P. O. BOX # 110341
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
FORMER COMPANY:
FORMER CONFORMED NAME: G-Zero Therapeutics, Inc.
DATE OF NAME CHANGE: 20121012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RUDNICK SETH
CENTRAL INDEX KEY: 0001184420
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38096
FILM NUMBER: 17964324
MAIL ADDRESS:
STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101
STREET 2: C/O ARALEZ PHARMACEUTICALS
CITY: MISSISSAUGA
STATE: A6
ZIP: L5N 0E4
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-07-11
0
0001560241
G1 Therapeutics, Inc.
GTHX
0001184420
RUDNICK SETH
C/O G1 THERAPEUTICS, INC.
79 T.W. ALEXANDER DRIVE
RESEARCH TRIANGLE PARK
NC
27709
1
0
0
0
Stock Option (right to buy)
15.55
2017-07-11
4
A
0
20000
0.00
A
2027-07-11
Common Stock
20000
20000
D
The stock option will vest in thirty-six monthly installments at the end of each successive month following July 11, 2017, subject to the Reporting Person's continued service as a director.
/s/ Caroline G. Gammill, Attorney-in-Fact
2017-07-13